Subscribe To

Price Alert Latest News Economic Calendar News

SCLX / Scilex (SCLX) Stock Fans, Mark Your Calendars for April 17

Scilex (NASDAQ: SCLX ) stock is plunging 15% after the company delayed its 2023 annual meeting from today until April 17. Scilex, which specializes in developing non-opioid pain treatments, indicated that it wants to give representatives of its shareholders more time to comply with a court order. Read More

Demo Live Account See Partner Details

Content Topics

Scilex

SCLX

Stock

Fans

Mark

Your

Calendars

April

sclx

Posted: Apr 6 2023, 09:49

Author Name: InvestorPlace

SCLX News

By The Motley Fool
October 9, 2023

Why Shares of Scilex Are Up Monday

Last week, the company said it is hiring a firm to look into manipulation of its stock. The company just got approval in February from the FDA for acu

By Benzinga
September 21, 2023

Top 4 Health Care Stocks That Could Lead To Your Biggest Gains In Q3 - Sight Sciences (NASDAQ:SGHT), Scilex Holding (NASDAQ:SCLX)

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

By GlobeNewsWire
June 16, 2023

Scilex Holding Company to Present Data on ELYXYB™ (celecoxib oral solution) at the 65th Annual Scientific Meeting of the American Headache Society, in Austin, TX.

PALO ALTO, Calif., June 16, 2023 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex”), a majority-owned subsidiary of Sorrento Ther

By The Motley Fool
April 28, 2023

Why Shares of Scilex Slumped This Week

While Scilex is not a debtor in Sorrento Therapuetics' bankruptcy proceedings, it is affected by them. Scilex plans to sell $300 million of stock.

By InvestorPlace
April 6, 2023

Scilex (SCLX) Stock Fans, Mark Your Calendars for April 17

Scilex (NASDAQ: SCLX ) stock is plunging 15% after the company delayed its 2023 annual meeting from today until April 17. Scilex, which specializes in

By The Motley Fool
January 20, 2023

Why Shares of Scilex Soared This Week

Improved revenue estimates and buyout rumors have been driving the stock higher.

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.